References
- Gersuny R. Ueber eine subcutane Prothese. Z. Heilkunde Wien Leipzig 21, 199–201 (1900) [Translation: Concerning a subcutaneous prosthesis. Plast. Reconstr. Surg.65, 525–527 (1980)].
- Eckstein H. Ueber subcutane und submuköse Hartparaffinprothesen. DtschMed. Wschr.32, 573 (1902).
- Glicenstein J. Les premiers “fillers”, vaseline et paraffine. Du miracle à la catastrophe. Ann. Chir. Plast. Esthét.52, 157–161 (2007).
- Maas CS, Papel ID, Greene D, Stoker DA. Complications of injectable synthetic polymers in facial augmentation. Dermatol. Surg.23, 871–877 (1997).
- Haneke E. Soft tissue augmentation with injectable fillers and implants. In: Facial Plastic Surgery. Vuyk HD, Lohuis PJFM (Eds). Hodder Arnold, London, UK 167–180 (2006).
- Wiest L. Wann sind welche Behandlungsmethoden für welche Falten sinnvoll? In: Standards und Trends in der operativen und onkologischen Dermatologie, Phlebologie und Proktologie. Fortschritte der Operativen und Onkologischen Dermatologie 17. Sebastian G, Stein A, Hackert I (Eds). Congress Compact Verl, Berlin, Germany 17–24 (2001).
- Sherris DA, Gassner HG. Botulinum toxin to minimize facial scarring. Facial Plast. Surg.18, 35–39 (2002).
- Scalfani AP, Romo T III. Collagen, human collagen, and fat: the search for a three-dimensional soft tissue filler. Facial Plast. Surg.17, 79–85 (2001).
- Beljaards RC, de Roos K-P, Bruins FG. NewFill for skin augmentation: a new filler or failure? Dermatol. Surg.31, 772–776 (2005).
- Bigata X, Ribera M, Bielsa I, Ferrandiz C. Adverse granulomatous reaction after cosmetic dermal silicone injection. Dermatol. Surg.27, 198–200 (2001).
- Bui P, Pons-Giraud A, Kuffer R, Plantier F, Nicolau P. Les produits injectables lentement et non résorbables. Ann. Chir. Plast. Esthét.49, 486–502 (2004).
- André P, Lowe NJ, Parc A, Clerici TH, Zimmermann U. Adverse reactions to dermal fillers: a review of European experiences. J. Cosmet. Laser Ther.7, 171–176 (2005).
- Ellis DA, Segall L. Review of non-FDA-approved fillers. Facial Plast. Surg. Clin. North Am.15, 239–246 (2007).
- Nicolau PJ. Long-lasting and permanent fillers: biomaterial influence over host tissue response. Plast. Reconstr. Surg.119, 2271–2286 (2007).
- Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol. Surg.33(Suppl. 2), S168–S175 (2007).
- Christensen LC, Breiting VB, Aasted A, Jörgensen A, Kebuladze I. Long term effects of polyacrylamide hydrogel (PAAG, Interfall/Contura SA) in human breast tissue. Plast. Reconstr. Surg.111, 1883–1888 (2003).
- von Bülow S, Pallua N. Efficacy and safety of polyacrylamide hydrogel for facial soft tissue augmentation in a 2-year follow-up: a prospective multicenter study for evluation of safety and aesthetic results in 101 patients. Plast. Reconstr. Surg.118(Suppl. 3), S85–S91 (2006).
- Leung KM, Yeoh GPS, Chan KW. Breast pathology in complications associated with polyacrylamide hydrogel (PAAG) mammoplasty. Hong Kong Med. J.13, 137–140 (2007).
- Kalantar -Hormozi A, Mozafari N, Rasti M. Adverse effects after use of polyacrylamide gel as a facial soft tissue filler. Aesth. Surg. J.28, 139–142 (2008).
- Webster RC, Fuleihan NS, Hamdan US, Gaunt IM, Smith RC. Injectable silicone: report of 17,000 facial treatments since 1962. Am. J. Cosm. Surg.3, 41–48 (1986).
- Benedetto AV, Lewis AT. Injecting 1000 centistoke liquid silicone with ease and precision. Dermatol. Surg.29, 211–214 (2003).
- Zappi E, Barnett JG, Zappi M, Barnett CR. The long-term host response to liquid silicone injected during soft tissue augmentation procedures: a microscopic appraisal. Dermatol. Surg.33, S186–S192 (2007).
- Barnett JG. Injectable silicone in dermatologic surgery. Presented at: Cosmoderm 2 – Laserderm 1. Trieste, Italy, 31 August–3 September 2002.
- Faure M. Complications des implants de silicone et autres matériaux dits inertes. Ann. Dermatol. Venereol.122, 455–459 (1995).
- James J, Carruthers A, Carruthers D. HIV-associated facial lipodystrophy. Dermatol. Surg.28, 979–986 (2002).
- Zimmermann US, Clerici TJ. The histological aspects of fillers complications. Semin. Cutan. Med. Surg.23, 241–250 (2004).
- Vargas-Machuca I, González-Guerra E, Angulo J, del Carmen Fariña M, Martín L, Requena L. Facial granulomas secondary to Dermalive microimplants: report of a case with istopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials. Am. J. Dermatopathol.28, 173–177 (2006).
- Rongioletti F. Complications granulomateuses des techniques de comblement. Ann. Dermatol. Venereol.135, 1S59–65 (2008).
- Panettiere P, Marchetti L, Accorsi D. Filler injection enhances the projection of the reconstructed nipple: an original easy technique. Aesth. Plast. Surg.29, 287–294 (2005).
- Piacquadio D, Smith S, Andersoqn R. A comparison of commercially available polymethylmethacrylate-based soft tissue fillers. Dermatol. Surg.34(Suppl. 1), S48–S52 (2008).
- Lemperle G, Hazan-Gauthier N, Lemperle M. PMMA microspheres (Artecoll) for skin and soft tissue augmentation. II. Clinical investigations. Plast. Reconstr. Surg.96, 627–634 (1995).
- Lemperle G, Hazan-Gauthier N, Lemperle M. PMMA microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesth. Plast. Surg.22, 356–365 (1998).
- Wiest LG, Landthaler M, Stolz W. Hautaugmentation mit Polymethylmethacrylat. In: Ästhetische und korrektive Dermatologie. Fortschritte der operativen und onkologischen Dermatologie 14. Konz B, Wörle B, Sander CA (Eds). Blackwell WissVerl, Berlin, Germany 196–202 (1999).
- Haneke E. Polymethyl methacrylate microspheres in collagen. Semin. Cutan. Med. Surg.23, 227–232 (2004).
- Alcalay J, Alkalay R, Gat A, Yorav S. Late-onset granulomatous reaction to Artecoll. Dermatol. Surg.29, 859–862 (2003).
- Sommer B, Heenan P, Sattler G. Lipogranulom nach implantierten Acryl-Perlen. In: Ästhetische und korrektive Dermatologie. Fortschritte der operativen und onkologischen Dermatologie 14. Blackwell WissVerl, Berlin, Germany 203–205 (1999).
- Fischer J, Metzler G, Schaller M. Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies. Arch. Dermatol.143, 507–510 (2007).
- Requena C, Izquierdo MJ, Navarro M et al. Adverse reactions to injectable aesthetic microimplants. Am. J. Dermatopathol.23, 197–202 (2001).
- Randhawa PS, Ramsay AD, Rubin JS. Foreign body reaction to polymethylsiloxane gel (Bioplastique) after vocal fold augmentation. J. Laryngol. Otol.122, 750–753 (2008).
- Niechajev I. Lip enhancement: surgical alternatives and histologic aspects. Plast. Reconstr. Surg.105, 1173–1183 (2000).
- Alam M, Gladstone H, Kramer EM et al. ASDS guidelines of care: injectable fillers. Dermatol. Surg.34, S115–S148 (2008).
- Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol. Surg.34, S92–S99 (2008).
- Narins RS, Jewell M, Rubin M et al. Clinical conference: management of rare events following dermal fillers – focal necrosis and angry red bumps. Dermatol. Surg.32, 426–434 (2006).
- Cronin TD, Gerow FJ. Augmentation mammoplasty: a natural feel. In: Transactions of the Third International Congress of Plastic Surgery. Excerpta Medica, Princeton, NJ, USA 41–49 (1964).
- Duffy D. Silicone. A critical review. Adv. Dermatol.5, 93–109 (1990).
- Miro-Mur F, Hindié M, Kandhaya-Pillai R, Tobajas V, Schwartz S Jr, Alijotas-Reig J. Medical-grade silicone induces release of proinflammatory cytokines in peripheral blood mononuclear cells without activating T cells. J. Biomed. Mater. Res. B Appl. Biomater. (2009) (Epub ahead of print).
- Katzin WE, Centeno JA, Feng LL, Kiley M, Mullick FG. Pathology of lymph nodes from patients with breast implants: a histologic and spectroscopic evaluation. Am. J. Surg. Pathol.29, 506–511 (2005).
- Laub DR, Kaplan EM. Complications following silicone injections for augmentation of the contours of the face. Plast. Reconstr. Surg. Plast. Reconstr. Surg.61, 888–891 (1978).
- Achauer BM. A serious complication following medical-grade silicone injection in the face. Plast. Reconstr. Surg.71, 251–253 (1983).
- Meigel W, Winzer M, Berg A, Wolff HH. Silikonom. Z. Hautkr.64, 815–816 (1989).
- Pearl RM, Mastruserio N, Pesqueira MJ, Cobb MW. Severe granulomatous reaction and facial ulceration occurring after subcutaneous silicone injection. Am. Acad. Dermatol.34, 849–852 (1996).
- Pimentel L, Barnadas M, Vidal D, Sancho F, Fontarnau R, Alomar A. Simultaneous presentation of silicone and silica granuloma: a case report. Dermatology205, 162–165 (2002).
- Lombardi T, Samson J, Plantier F, Husson C, Kuffer R. Orofacial granulomas after injection of cosmetic fillers: histopathologic and clinical study of 11 cases. J. Oral Pathol. Med.33, 115–120 (2004).
- Rapaport M. Silicone injections revisited. Dermatol. Surg.28, 594–595 (2002).
- Jansen T, Kossmann E, Plewig G. Silikonome. Ein interdisziplinäres Problem. Hautarzt44, 636–643 (1993).
- Senet P, Bachelez H, Ollivaud L, Vignon-Pennamen D, Dubertret L. Minocycline for the treatment of cutaneous silicone granulomas. Br. J. Dermatol.140, 985–987 (1999).
- Arin MJ, Bäte J, Krieg T, Hunzelmann N. Silicone granuloma of the face treated with minocycline. J Am. Acad. Dermatol.52(2 Suppl. 1), 53–56 (2005).
- Pasternack FR, Fox LP, Engler DE. Silicone granulomas treated with etanercept. Arch. Dermatol.141, 13–15 (2005).
- Desai AM, Browning J, Rosen T. Etanercept therapy for silicone granuloma. J. Drugs Dermatol.5, 894–896 (2006).
- Baumann LS, Halem ML. Lip silicone granulomatous foreign body reaction treated with Aldara (imiquimod 5%). Dermatol. Surg.29, 429–432 (2003).
- Lai YL, Weng CJ, Noordhoff MS. Breast reconstruction with TRAM flap after subcutaneous mastectomy for injected material (siliconoma). Br. J. Plast. Surg.54(4), 331–334 (2001).
- Frey HP, Lemperle G, Exner K. Silikonome und rheumatische symptomatik – eine bekannte und eine fragliche komplikation von Silikonimplantaten [Siliconoma and rheumatic symptoms – a familial and a questionable complication of silicone implantation]. Handchir. Mikrochir. Plast. Chir.24(4), 171–177 (1992).
- Duffy MJ, Woods JE. Health risks of failed silicone gel breast implants: a 30-year clinical experience. Plast. Reconstr. Surg.94, 295–299 (1994).
- Reda-Lari A. Augmentation of the malar area with polacrylamid hydrogel: experience with more than 1300 patients. Aesthet. Surg. J.28, 131–138 (2008).
- Ashinoff R. Soft tissue augmentation. Clin. Plast. Surg.27, 479–487 (2000).
- Cheng NX, Wang YL, Wang JH, Zhang XM, Zhong H. Complications of breast augmentation with injected hydrophilic polyacrylamide gel. Aesth. Plast. Surg.26, 375–382 (2002).
- Lee CJ, Kim SG, Kim L, Choi MS, Lee SI. Unfavorable findings following breast augmentation using injected polyacrylamide hydrogel. Plast. Reconstr. Surg.114, 1967–1968 (2004).
- Cheng NX, Xu SL, Deng H et al. Migration of implants: a problem with injectable polyacrylamide gel in aesthetic plastic surgery. Aesth. Plast. Surg.30, 215–225 (2006).
- Lin WC, Hsu GC, Hsu YC et al. A late complication of augmentation mammoplasty by polyacrylamide hydrogel injection: ultrasound and magnetic resonance imaging findings of huge galactocele formation in a puerperal woman with pathological correlation. Breast J.14, 584–587 (2008).
- Toy BR, Frank PJ. Outbreak of mycobacterium abscessus infection after soft tissue augmentation. Dermatol. Surg.29, 971–973 (2003).
- Christensen L, Breiting V, Vuust J, Hogdall E. Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): causes and treatment. Eur. J. Plast. Surg.28, 464–471 (2006).
- Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesth. Plast. Surg.29, 34–48 (2005).
- Zarini E, Supino R, Pratesi G, Laccabue D et al. Biocompatibility and tissue interactions of a new filler material for medical use. Plast. Reconstr. Surg.114, 934–942 (2004).
- Pacini S, Ruggiero M, Morucci G et al. Bio-Alcamid: a novelty for reconstructive and cosmetic surgery. Ital. J. Anat. Embryol.107, 209–214 (2002).
- Pacini S, Ruggiero M, Morucci G et al. Bio-Alcamid: a novel prosthetic polymer, does not interfere with morphological and functional characteristics of human fibroblasts. Plast. Reconsgtr. Surg.111, 489–491 (2003).
- Protopapa C, Giuseppe S, Caporale D, Cammarota N. Bio-Alcamid® in drug-induced lipodystrophy. J. Cosmet. Laser Ther.5, 226–230 (2003).
- Karim RB, de Lint CA, van Galen SR et al. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients. Aesth. Plast. Surg.32, 873–878 (2008).
- Hönig J. Cheek augmentation with Bio-Alcamid in facial lipoatrophy in HIV seropositive patients. J. Craniofac. Surg.19, 1085–1088 (2008).
- Ellis D, Sardesai MG. Bio-Alcamid: an alternative to fat transfer. Facial Plast. Surg. Clin. North Am.16, 429–433 (2008).
- Jones DH, Carruthers A, Fitzgerald R, Sarantopoulos GP, Binder S. Late-appearing abscesses after injections of nonabsorbable hydrogel polymer for HIV-associated facial lipoatrophy. Dermatol. Surg.33(Suppl. 2), S193–S198 (2007).
- Goldan O, Georgiou I, Grabov-Nardini G et al. Early and late complications after a nonabsorbable hydrogel polymer injection: a series of 14 patients and novel management. Dermatol. Surg.33(Suppl. 2), S199–S206 (2007).
- Bergeret-Galley C, Latouche X, Illouz YG. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesth. Plast. Surg.25, 249–255 (2001).
- Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesth. Plast. Surg.27, 354–366 (2003).
- Sidwell RU, Dhillon AP, Butler PE, Rustin MH. Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin. Exp. Dermatol.29, 630–632, (2004).
- Angus JE, Affleck AG, Leach IH, Millard LG. Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel. Br. J. Dermatol.155, 1077–1078 (2006).
- González-Vela MC, Armesto S, González-López MA, Fernández-Llaca JH, Val-Bernal JF. Perioral granulomatous reaction to Dermalive. Dermatol. Surg.34, 986–988 (2008).
- Gamo R, Pinedo F, Vicente J et al. Keratoacanthoma-like reaction after a hyaluronic acid and acrylic hydrogel cosmetic filler. Dermatol. Surg.34, 954–959 (2008).
- Wolfram D, Tzankov A, Piza-Katzer H. Surgery for foreign body reactions due to injectable fillers. Dermatology213, 300–304 (2006).
- Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast. Reconstr. Surg.118(Suppl. 3), S92–S107 (2006).
- Cohen SR, Berner CF, Busso M et al. ArteFill: a long-lasting injectable wrinkle filler material – summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast. Reconstr. Surg.118(Suppl. 3), S64–S76 (2006).
- Gelfer A, Carruthers A, Carruthers J, Jang F, Bernstein SC. The natural history of polymethylmethacrylate microspheres granulomas. Dermatol. Surg.33, 614–620 (2007).
- Conejo-Mir JS, Sanz Guirado S, Angel Muñoz M. Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol. Surg.32, 1079–1081 (2006).
- Odo MEY, Odo LM, Nemoto NCF, Cucé LC. Treatment of nodules caused by polymethylmethacrylate. A pilot sudy. Dermatol. Surg.34, 1746–1749 (2008).
- Eppley BL, Sidner RA, Sadove AM. Adequate preclinical testing of bioplastique injectable material? Plast. Reconstr. Surg.89, 157–158 (1992).
- Baijens L, Speyer R, Linssen M, Ceulen R, Manni JJ. Rejection of injectable silicone “Bioplastique” used for vocal fold augmentation. Eur. Arch. Otorhinolaryngol.264, 565–568 (2007).
Websites
- Injectable micro-implants www.lipaugmentation.com/microimplants.htm#1
- Patients permanently scarred by Dermalive implants www.plasmetic.com/skin/dermal-fillers/patients-permanently-scarred-by-dermalive-implants.html
- Dermagen adverse effects www.carlaantonelli.com/foros/viewtop0ic.php?
- Kuhravital www.kuhravital.com/en/prods_kuhra/prods_kuhra.htm
- Emedicine emedicine.medscape.com/article/843730-overview